We at GelbChem are thrilled to supply the majority of enzyme activity and biomarker assay reagents for the ScreenPlus Pilot Study in 2021-2026.
#ScreenPlus is a voluntary newborn screening (NBS) pilot study in New York that can help us understand how well NBS works for certain rare diseases and can help us identify these diseases in newborns as early as possible.
Read more about ScreenPlus: https://einsteinmed.org/research/screenplus/
Comments